joining us for that is maya goldman, the health care reporter f axios. good morning to you. guest: good morning. thank you for having me. host: could you break down whato do. guest: essentially this case is determining the access to medication abortion. which is how the majority abortions in the country are performed. in a lot of ways it's relitigating access to abortion in the country. more specifically, the case deals with whether the federal government, specifically the f.d.a., was acting lawfully when it loosened restrictions on how people can access medication abortion, mifepristone, the specific pill. in question. and whether the■p f.a followed the appropriate approval. host: who is bringing up this case? guest: originally inep of anti-s sued the federal government approval of mifepristone, approved in 2000, was inappropriate. they wanted the drug removed from the market entirely. a couple months ago a judge in texas, conservative judge, sided with those doctors. an appeals court quickly said, well, we don't think that this should be entirely removed from the market, b